Indian equity markets are likely to begin Thursday’s session on a cautious note. Trends from global indices and GIFT Nifty suggest a lower opening for domestic benchmarks amid mixed global cues. Despite the subdued start, several listed companies are expected to remain in focus following fresh business updates, regulatory developments, operational numbers, and corporate announcements.
Stocks to Watch Today – January 8, 2026
-
Infosys partnered with Cognition to accelerate AI-led value creation for global enterprises.
-
Tata Steel reported 11.4% YoY growth in Q3 India production, while delivery volumes rose 14% YoY.
-
JSW Steel saw Fitch revise its ‘BB’ rating outlook to Rating Watch Positive.
-
Angel One will consider a stock split; December equity market share rose 62 bps, while Q3 market share increased 34 bps YoY.
-
HUDCO signed an MoU with the Chhattisgarh government for up to ₹1 lakh crore financial assistance for housing and infrastructure projects.
-
IRB Infrastructure reported 11.7% YoY growth in December gross toll collection at ₹753.8 crore.
-
NCL Industries recorded 5% YoY growth each in Q3 cement production and dispatches.
-
Gland Pharma received US FDA approval for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% (OTC).
-
Sri Lotus Developers entered a development agreement with Abhishek Bachchan for a GIFT City project with ~1 million sq ft built-up area.
-
Balaji Amines said its Solapur unit expansion is eligible for ₹250 crore+ government incentives.
-
Panacea Biotec completed enrollment for the Phase-III Dengiall clinical trial.
-
Kalpataru Projects International is nearing closure of a ₹775 crore project sale.
-
Zaggle Prepaid Ocean Services signed an agreement with Cubastion Consulting for an employee purchase programme.
-
Lemon Tree Hotels clarified that reports of Warburg Pincus acquiring a stake are factually incorrect.
-
Cipla is evaluating the impact of US FDA observations related to supply partner Pharmathen.
-
DGCA sought airline fare data for December amid flight disruptions, alongside a probe by the Competition Commission of India.
-
Meesho announced the resignation of Megha Agarwal, General Manager – Business.
-
Senores Pharmaceuticals will issue 11.7 lakh warrants to promoters via preferential issue at ₹812 per warrant.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.